Determination of lamivudine/stavudine/efavirenz in human serum using liquid chromatography/electrospray tandem mass spectrometry with ionization polarity switch

This publication has 13 references indexed in Scilit:

• Antiretrovirals: Simultaneous Determination of Five Protease Inhibitors and Three Nonnucleoside Transcriptase Inhibitors in Human Plasma by a Rapid High-Performance Liquid Chromatography–Mass Spectrometry Assay
  Therapeutic Drug Monitoring, 2001
• Mechanistic investigation of ionization suppression in electrospray ionization
  Published by American Chemical Society (ACS) ,2000
• Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometry
  Journal of Pharmaceutical and Biomedical Analysis, 2000
• Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1999
• Efficacy and Tolerability of Stavudine plus Lamivudine in Treatment-Naive and Treatment-Experienced Patients with HIV-1 Infection
  Annals of Internal Medicine, 1998
• Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
  New England Journal of Medicine, 1997
• Antiretroviral Therapy for HIV Infection in 1997
  JAMA, 1997
• Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection
  Science, 1997
• High-performance Liquid Chromatography/Atmospheric Pressure Chemical Ionization Mass Spectrometry with Ionization Polarity Switching for the Determination of Selected Pesticides
  Rapid Communications in Mass Spectrometry, 1997
• Determination of stavudine, a new antiretroviral agent, in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1992